CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host
its first quarter 2011 investor update conference call and webcast at
8:30 a.m. Eastern Time on Thursday, May 12, 2011. Individuals interested
in participating in the call should dial (888) 820-9416 (U.S. and
Canada) or (913) 312-1416 (international) using conference ID number
1229502. To access the webcast, please visit the Investors section of
Ironwood's website at www.ironwoodpharma.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
The call will be available for replay via telephone starting May 12,
2011, at approximately 11:30 a.m. Eastern Time, running through 11:59
p.m. Eastern Time on May 26, 2011. To listen to the replay, dial (888)
203-1112 (U.S. and Canada) or (719) 457-0820 (international) using
conference ID number 1229502. The archived webcast will be available on
Ironwood's website for 14 days beginning approximately one hour after
the call.
About Ironwood Pharmaceuticals
Ironwood
Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical
company dedicated to the art and science of great drugmaking.
Linaclotide, Ironwood's GC-C agonist, is in Phase 3 clinical development
for the treatment of irritable bowel syndrome with constipation (IBS-C)
and chronic constipation. Ironwood also has a growing pipeline of
additional drug candidates in earlier stages of development. Ironwood is
located in Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media